313 related articles for article (PubMed ID: 27031441)
1. Reconstitution of ST2 (IL-1R4) specific for IL-33 activity; no suppression by IL-1Ra though a common chain IL-1R3 (IL-1RAcP) shared with IL-1.
Jo S; Kim E; Kwak A; Lee J; Hong J; Lee J; Youn S; Bae S; Kim B; Ryoo S; Kang TB; Her E; Choi DK; Kim YS; Lee Y; Jhun H; Kim S
Cytokine; 2016 Jul; 83():33-40. PubMed ID: 27031441
[TBL] [Abstract][Full Text] [Related]
2. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.
Chackerian AA; Oldham ER; Murphy EE; Schmitz J; Pflanz S; Kastelein RA
J Immunol; 2007 Aug; 179(4):2551-5. PubMed ID: 17675517
[TBL] [Abstract][Full Text] [Related]
3. Molecular Basis of Selective Cytokine Signaling Inhibition by Antibodies Targeting a Shared Receptor.
Fields JK; Kihn K; Birkedal GS; Klontz EH; Sjöström K; Günther S; Beadenkopf R; Forsberg G; Liberg D; Snyder GA; Deredge D; Sundberg EJ
Front Immunol; 2021; 12():779100. PubMed ID: 35003094
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory function of Fc-ST2 depends on cell type; IL-1RAcP and ST2 are necessary but insufficient for IL-33 activity.
Hong K; Lee Y; Lee S; Hong S; Bae S; Hong J; Choi J; Jhun H; Kwak A; Kim E; Jo S; Kang T; Cho YS; Kim YG; Kim S
Immunol Res; 2013 May; 56(1):122-30. PubMed ID: 23435764
[TBL] [Abstract][Full Text] [Related]
5. IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor.
Günther S; Deredge D; Bowers AL; Luchini A; Bonsor DA; Beadenkopf R; Liotta L; Wintrode PL; Sundberg EJ
Immunity; 2017 Sep; 47(3):510-523.e4. PubMed ID: 28930661
[TBL] [Abstract][Full Text] [Related]
6. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
7. Effects of IL-33/ST2 pathway in acute inflammation on tissue damage, antioxidative parameters, magnesium concentration and cytokines profile.
Stankovic MS; Janjetovic K; Velimirovic M; Milenkovic M; Stojkovic T; Puskas N; Zaletel I; De Luka SR; Jankovic S; Stefanovic S; Japundzic-Zigon N; Petronijevic ND; Trajkovic V; Trbovich AM
Exp Mol Pathol; 2016 Aug; 101(1):31-7. PubMed ID: 27222019
[TBL] [Abstract][Full Text] [Related]
8. The Interleukin-1 Family.
Yazdi AS; Ghoreschi K
Adv Exp Med Biol; 2016; 941():21-29. PubMed ID: 27734407
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 Receptor Antagonist Has a Novel Function in the Regulation of Matrix Metalloproteinase-13 Expression.
Goto H; Ishihara Y; Kikuchi T; Izawa A; Ozeki N; Okabe E; Kamiya Y; Ozawa Y; Mizutani H; Yamamoto G; Mogi M; Nakata K; Maeda H; Noguchi T; Mitani A
PLoS One; 2015; 10(10):e0140942. PubMed ID: 26474296
[TBL] [Abstract][Full Text] [Related]
10. Altered interleukin-1 receptor antagonist and interleukin-18 mRNA expression in myocardial tissues of patients with dilatated cardiomyopathy.
Westphal E; Rohrbach S; Buerke M; Behr H; Darmer D; Silber RE; Werdan K; Loppnow H
Mol Med; 2008; 14(1-2):55-63. PubMed ID: 17948066
[TBL] [Abstract][Full Text] [Related]
11. IL-33/ST2 Axis in Organ Fibrosis.
Kotsiou OS; Gourgoulianis KI; Zarogiannis SG
Front Immunol; 2018; 9():2432. PubMed ID: 30405626
[TBL] [Abstract][Full Text] [Related]
12. Contribution of IL-1 to resistance to Streptococcus pneumoniae infection.
Kafka D; Ling E; Feldman G; Benharroch D; Voronov E; Givon-Lavi N; Iwakura Y; Dagan R; Apte RN; Mizrachi-Nebenzahl Y
Int Immunol; 2008 Sep; 20(9):1139-46. PubMed ID: 18596024
[TBL] [Abstract][Full Text] [Related]
13. IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria.
Reverchon F; Mortaud S; Sivoyon M; Maillet I; Laugeray A; Palomo J; Montécot C; Herzine A; Meme S; Meme W; Erard F; Ryffel B; Menuet A; Quesniaux VFJ
PLoS Pathog; 2017 Apr; 13(4):e1006322. PubMed ID: 28448579
[TBL] [Abstract][Full Text] [Related]
14. IL-1 family cytokines and receptors in IgG4-related disease.
Capecchi R; Italiani P; Puxeddu I; Pratesi F; Tavoni A; Boraschi D; Migliorini P
Cytokine; 2018 Feb; 102():145-148. PubMed ID: 28823915
[TBL] [Abstract][Full Text] [Related]
15. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.
Palmer G; Lipsky BP; Smithgall MD; Meininger D; Siu S; Talabot-Ayer D; Gabay C; Smith DE
Cytokine; 2008 Jun; 42(3):358-64. PubMed ID: 18450470
[TBL] [Abstract][Full Text] [Related]
16. ST2 Signaling in the Tumor Microenvironment.
Chang CP; Hu MH; Hsiao YP; Wang YC
Adv Exp Med Biol; 2020; 1240():83-93. PubMed ID: 32060890
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
[TBL] [Abstract][Full Text] [Related]
18. Distinct expression of interleukin-1α, interleukin-1β, and interleukin-1 receptor antagonist in testicular tissues and cells from human biopsies with normal and abnormal histology.
Abu Elheija M; Dyomin V; Ganaiem M; Lunenfeld E; Vardy NS; Huleihel M
J Interferon Cytokine Res; 2011 Apr; 31(4):401-8. PubMed ID: 21235388
[TBL] [Abstract][Full Text] [Related]
19. Extracellular regulation of interleukin (IL)-1beta through lung epithelial cells and defective IL-1 type II receptor expression.
Coulter KR; Wewers MD; Lowe MP; Knoell DL
Am J Respir Cell Mol Biol; 1999 May; 20(5):964-75. PubMed ID: 10226066
[TBL] [Abstract][Full Text] [Related]
20. Clock-dependent temporal regulation of IL-33/ST2-mediated mast cell response.
Kawauchi T; Ishimaru K; Nakamura Y; Nakano N; Hara M; Ogawa H; Okumura K; Shibata S; Nakao A
Allergol Int; 2017 Jul; 66(3):472-478. PubMed ID: 28259547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
